Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2010.62
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC